Transmembrane domain V of the endothelin-A receptor is a binding domain of ETA-selective TTA-386-derived photoprobes

Biochemistry

Volumn 44, Issue 21, 2005, Pages 7844-7854

  Tessier, Sophie ^a   Boivin, Stéphane ^a   Aubin, Jacinthe ^a   Lampron, Philipe ^a   Detheux, Michel ^b   Fournier, Alain ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b Euroscreen   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOLOGICAL MEMBRANES; CELLS; DRUG PRODUCTS; PHOTOREACTIVITY; PHOTOSENSITIVITY; POLYPEPTIDES;

BINDING DOMAIN; PHOTOPROBES; PHOTOSENSITIVE ANALOGS; TRANSMEMBRANE DOMAIN;

PROTEINS;

BENZENE DERIVATIVE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; LEVO 4 BENZOYLPHENYLALANINE; PHOTOSENSITIZING AGENT; TTA 386; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; ISOTOPE LABELING; MALE; NONHUMAN; PHOTOAFFINITY LABELING; PHOTOREACTIVITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; RAT;

AMINO ACID SEQUENCE; ANIMALS; AORTA, THORACIC; CHO CELLS; CRICETINAE; ENDOTHELIN-1; GUINEA PIGS; HUMANS; LUNG; MALE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PHOTOAFFINITY LABELS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; TRANSFECTION;

EID: 19644398568     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0500933     Document Type: Article

References (28)

1. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., and Masaki, T. (1988) A novel potent vasoconstrictor peptide produced by vascular entothelial cells, Nature 332, 411-415.
2. Mateo, A. O., and DeArtinano, A. (1997) Highlights on endothelins: a review, Phamacol. Res. 36, 339-351.
3. Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K., and Masaki, T. (1989) The human endpthelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes, Proc. Natl. Acad. Sci. U.S.A. 86, 2863-2867.
4. Masaki, T., Vane, J. R., and Vanhoutte, P. M. (1994) International Union of Pharmacology nomenclature of endothelin receptors, Pharmacol. Rev. 46, 137-142.
5. Sakurai, T., Yanagisawa, M., and Masaki, T. (1992) Molecular characterization of endothelin receptors, Trends Pharmacol. Sci. 13, 103-108.
6. Shetty, S. S., Okada, T., Webb, R. L., DelGrande, D., and Lappe, R. W. (1993) Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle, Biochem. Biophys. Res. Commun. 191, 459-464.
7. Masaki, T. (2004) Historical review: endothelin, Trends Pharmacol. Sci. 25, 219-224.
8. Touyz, R. M., and Schiffrin, E. L. (2003) Role of endothelin in human hypertension, Can. J. Physiol. Pharmacol. 81, 533-541.
9. Orth, S. R., Viedt, C., Amann, K., and Ritz, E. (2001) Endothelin in renal diseases and cardiovascular remodeling in renal failure, Intern. Med. 40, 285-291.
10. Schmitz-Spanke, S., and Schipke, J. D. (2000) Potential role of endothelin-1 and endothelin antagonists in cardiovascular diseases, Basic Res. Cardiol. 95, 290-298.
11. Masaki, T., Ninomiya, H., Sakamoto, A., and Okamoto, Y., (1999) Structural basis of the function of endothelin receptor, Mol. Cell. Biochem. 190, 153-156.
12. Breu, V., Hashido, K., Broger, C., Miyamoto, C., Furuichi, Y., Hayes, A., Kalina, B., Loffler, B. M., Ramuz, H., and Clozel, M. (1995) Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors, Eur. J. Biochem. 231, 266-270.
13. Krystek, S. R., Jr., Patel, P. S., Rose, P. M., Fisher, S. M., Kienzle, B. K., Lach, D. A., Liu, E. C., Lynch, J. S., Novotny, J., and Webb, M. L. (1994) Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity, J. Biol. Chem. 17, 12383-12386.
14. Lee, J. A., Elliott, J. D., Sutiphong, J. A., Friesen, W. J., Ohlstein, E. H., Stadel, J. M., Gleason, J. G., and Peishoff, C. E. (1994) Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptor, Proc. Natl. Acad. Sci. U.S.A. 91, 7164-7168.
15. Adachi, M., Furuichi, Y., and Miyamoto, C. (1994) Identification of a ligand-binding site of the human endothelin-A receptor and specific regions required for ligand selectivity, Eur. J. Biochem. 220, 37-43.
16. Zhu, G., Wu, L. H., Mauzy, C., Egloff, A. M., Mirzadegan, T., and Chung, F. Z. (1992) Replacement of lysine-181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling, J. Cell. Biochem. 50, 159-164.
17. Sakamoto, A., Yanagisawa, M., Sawamura, T., Enoki, T., Ohtani, T., Sakurai, T., Nakao, K., Toyo-oka, T., and Masaki, T. (1993) Distinct subdomains of human endothelin receptors determine their selectivity to endothelin A-selective antagonist and endothelin B-selective agonists, J. Biol. Chem. 268, 8547-8553.
18. A receptor required for ligand binding, FEBS Lett. 2, 179-183.
19. Kauer, J. C., Erickson-Viitanen, S., Wolfe, H. R., Jr., and DeGrado, W. F. (1986) p-Benzoyl-L-phenylalanine, a new photoreactive amino acid. Photolabeling of calmodulin with a synthetic calmodulin-binding peptide, J. Biol. Chem. 261, 10695-10700.
20. Bremer, A. A., Leeman, S. E., and Boyd, N. D. (2001) Evidence for spatial proximity of two distinct receptor regions in the substance P (SP) neurokinin-1 receptor (NK-1R) complex obtained by photolabeling the NK-1R with p-benzoylphenylalanine3-SP, J. Biol. Chem. 276, 22857-22861.
21. Pérodin, J., Deraet, M., Auger-Messier, M., Boucard, A. A., Rihakova, L., Beaulieu, M.-E., Lavigne, P., Parent, J.-L., Guillemette, G., Leduc, R., and Escher, E. (2002) Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor, Biochemistry 41, 14348-14356.
22. Boucard, A. A., Sauvé, S. S., Guillemette, G., Escher, E., and Leduc, R. (2003) Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain, Biochem. J. 370, 829-838.
23. A receptor distribution, J. Cardiovasc. Pharmacol. 22, S128-131.
24. 125I]TTA-386, ETA-selective antagonist, Neuropeptides 31, 345-349.
25. Bunin, B. (1998) Combinatorial solid-phase synthesis, in The Combinatorial Index, pp 77-212, Academic Press, San Diego, CA.
26. B receptor, Biochem. Biophys. Res. Commun. 185, 867-873.
27. Boucard, A. A., Wilkes, B. C., Laporte, S. A., Escher, E., Guillemette, G., and Leduc, R. (2000) Photolabeling identifies position 172 of the human AT1 receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure, Biochemistry 39, 9662-9670.
28. Boivin, S., Tessier, S., Aubin, J., Lampron, P., Detheux, M., and Fournier, A. (2004) Identification of a binding domain of the endothelin-B receptor using a selective IRL-1620-derived photoprobe, Biochemistry 43, 11516-11525.